About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
Contact:
sachin.veerabhadrappa@external.merckgroup.com
Últimas notas de prensa
- 18 Aug 2019 - Merck Granted 20 CRISPR Patents Total Worldwide
- 07 Dec 2020 - Press Headline - ROW AEM-1789$ ¢ £ € ¥ ¥ ₹ ₽ 元 ≠
- 01 Dec 2020 - Headline-NA
- 04 Jun 2020 - heading na
- Más notas de prensa
Para seguir leyendo, inicie sesión o cree una cuenta.
¿No tiene una cuenta?